EA200802171A1 - СПОСОБ ПОЛУЧЕНИЯ 2-[4-(4-ФТОР-2-МЕТИЛ-1H-ИНДОЛ-5-ИЛОКСИ)-5-МЕТИЛПИРРОЛО[2,1-f][1,2,4]ТРИАЗИН-6-ИЛОКСИ]-1-МЕТИЛЭТИЛОВОГО ЭФИРА [(1R),2S]-2-АМИНОПРОПИОНОВОЙ КИСЛОТЫ - Google Patents
СПОСОБ ПОЛУЧЕНИЯ 2-[4-(4-ФТОР-2-МЕТИЛ-1H-ИНДОЛ-5-ИЛОКСИ)-5-МЕТИЛПИРРОЛО[2,1-f][1,2,4]ТРИАЗИН-6-ИЛОКСИ]-1-МЕТИЛЭТИЛОВОГО ЭФИРА [(1R),2S]-2-АМИНОПРОПИОНОВОЙ КИСЛОТЫInfo
- Publication number
- EA200802171A1 EA200802171A1 EA200802171A EA200802171A EA200802171A1 EA 200802171 A1 EA200802171 A1 EA 200802171A1 EA 200802171 A EA200802171 A EA 200802171A EA 200802171 A EA200802171 A EA 200802171A EA 200802171 A1 EA200802171 A1 EA 200802171A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- iloxi
- methyl
- methylpyrrolo
- triazin
- indol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Изобретение относится к усовершенствованному способу получения 2-[4-(4-фтор-2-метил-1Н-индол-5-илокси)-5-метилпирроло[2,1-f][1,2,4]триазин-6-илокси]-1-метил этилового эфира [(1R),2S]-2-аминопропионовой кислоты формулы (I). Соединение формулы (I) является полезным при лечении определенных видов рака.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74530006P | 2006-04-21 | 2006-04-21 | |
PCT/US2007/066911 WO2007124332A1 (en) | 2006-04-21 | 2007-04-19 | PROCESS FOR THE PREPARATION OF [(1R), 2S]-2-AMINOPROPIONIC ACID 2-[4-(4-FLUORO-2-METHYL-1H-INDOL-5-YLOXY)-5-METHYLPYRROLO[2,1-f][1,2,4]TRIAZIN-6-YLOXY]-1-METHYLETHYL ESTER |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200802171A1 true EA200802171A1 (ru) | 2009-08-28 |
EA019693B1 EA019693B1 (ru) | 2014-05-30 |
Family
ID=38357966
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200802171A EA019693B1 (ru) | 2006-04-21 | 2007-04-19 | СПОСОБ ПОЛУЧЕНИЯ 2-[4-(4-ФТОР-2-МЕТИЛ-1H-ИНДОЛ-5-ИЛОКСИ)-5-МЕТИЛПИРРОЛО[2,1-f][1,2,4]ТРИАЗИН-6-ИЛОКСИ]-1-МЕТИЛЭТИЛОВОГО ЭФИРА [(1R),2S]-2-АМИНОПРОПИОНОВОЙ КИСЛОТЫ |
Country Status (23)
Country | Link |
---|---|
US (1) | US7671199B2 (ru) |
EP (1) | EP2010538B1 (ru) |
JP (1) | JP5203353B2 (ru) |
KR (1) | KR101423789B1 (ru) |
CN (1) | CN101472927B (ru) |
AR (1) | AR060622A1 (ru) |
AU (1) | AU2007240453B2 (ru) |
BR (1) | BRPI0710691A2 (ru) |
CA (1) | CA2650059A1 (ru) |
CL (2) | CL2007001141A1 (ru) |
DK (1) | DK2010538T3 (ru) |
EA (1) | EA019693B1 (ru) |
ES (1) | ES2399379T3 (ru) |
HR (1) | HRP20130099T1 (ru) |
IL (1) | IL194715A (ru) |
MX (1) | MX2008013232A (ru) |
NO (1) | NO20084326L (ru) |
PE (1) | PE20080193A1 (ru) |
PL (1) | PL2010538T3 (ru) |
PT (1) | PT2010538E (ru) |
SI (1) | SI2010538T1 (ru) |
TW (1) | TWI378100B (ru) |
WO (1) | WO2007124332A1 (ru) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009511440A (ja) * | 2005-09-27 | 2009-03-19 | ブリストル−マイヤーズ スクイブ カンパニー | [(1R),2S]−2−アミノプロピオン酸2−[4−(4−フルオロ−2−メチル−1H−インドール−5−イルオキシ)−5−メチルピロロ[2,1−f][1,2,4]トリアジン−6−イルオキシ]−1−メチルエチルエステルの結晶形 |
US20120135875A1 (en) * | 2008-02-29 | 2012-05-31 | Bristol-Myers Squibb Company | Methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators |
ES2539620T3 (es) | 2008-12-19 | 2015-07-02 | Cephalon, Inc. | Pirrolotriazina como inhibidor de ALK y de JAK2 |
US11860139B2 (en) | 2018-10-08 | 2024-01-02 | Applied Photophysics Limited | System and method for analysing the composition of a quenched flow reaction liquid |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6982265B1 (en) * | 1999-05-21 | 2006-01-03 | Bristol Myers Squibb Company | Pyrrolotriazine inhibitors of kinases |
TWI329112B (en) * | 2002-07-19 | 2010-08-21 | Bristol Myers Squibb Co | Novel inhibitors of kinases |
TWI272271B (en) * | 2002-07-19 | 2007-02-01 | Bristol Myers Squibb Co | Process for preparing certain pyrrolotriazine compounds |
US7432373B2 (en) * | 2004-06-28 | 2008-10-07 | Bristol-Meyers Squibb Company | Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors |
US20050288290A1 (en) * | 2004-06-28 | 2005-12-29 | Borzilleri Robert M | Fused heterocyclic kinase inhibitors |
US7393667B2 (en) * | 2005-05-31 | 2008-07-01 | Bristol-Myers Squibb Company | Stereoselective reduction process for the preparation of pyrrolotriazine compounds |
JP2009511440A (ja) * | 2005-09-27 | 2009-03-19 | ブリストル−マイヤーズ スクイブ カンパニー | [(1R),2S]−2−アミノプロピオン酸2−[4−(4−フルオロ−2−メチル−1H−インドール−5−イルオキシ)−5−メチルピロロ[2,1−f][1,2,4]トリアジン−6−イルオキシ]−1−メチルエチルエステルの結晶形 |
-
2007
- 2007-04-19 AU AU2007240453A patent/AU2007240453B2/en not_active Ceased
- 2007-04-19 JP JP2009506761A patent/JP5203353B2/ja not_active Expired - Fee Related
- 2007-04-19 SI SI200731167T patent/SI2010538T1/sl unknown
- 2007-04-19 DK DK07760872.7T patent/DK2010538T3/da active
- 2007-04-19 WO PCT/US2007/066911 patent/WO2007124332A1/en active Application Filing
- 2007-04-19 PT PT77608727T patent/PT2010538E/pt unknown
- 2007-04-19 MX MX2008013232A patent/MX2008013232A/es active IP Right Grant
- 2007-04-19 CN CN2007800232897A patent/CN101472927B/zh active Active
- 2007-04-19 CA CA002650059A patent/CA2650059A1/en not_active Abandoned
- 2007-04-19 EA EA200802171A patent/EA019693B1/ru not_active IP Right Cessation
- 2007-04-19 KR KR1020087025577A patent/KR101423789B1/ko active IP Right Grant
- 2007-04-19 EP EP07760872A patent/EP2010538B1/en active Active
- 2007-04-19 PL PL07760872T patent/PL2010538T3/pl unknown
- 2007-04-19 BR BRPI0710691-2A patent/BRPI0710691A2/pt not_active IP Right Cessation
- 2007-04-19 ES ES07760872T patent/ES2399379T3/es active Active
- 2007-04-20 CL CL2007001141A patent/CL2007001141A1/es unknown
- 2007-04-20 US US11/737,787 patent/US7671199B2/en active Active
- 2007-04-20 PE PE2007000492A patent/PE20080193A1/es not_active Application Discontinuation
- 2007-04-20 AR ARP070101727A patent/AR060622A1/es unknown
- 2007-04-20 TW TW096114144A patent/TWI378100B/zh not_active IP Right Cessation
-
2008
- 2008-10-12 IL IL194715A patent/IL194715A/en not_active IP Right Cessation
- 2008-10-16 NO NO20084326A patent/NO20084326L/no not_active Application Discontinuation
-
2010
- 2010-05-28 CL CL2010000554A patent/CL2010000554A1/es unknown
-
2013
- 2013-02-05 HR HRP20130099TT patent/HRP20130099T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
AU2007240453A1 (en) | 2007-11-01 |
PE20080193A1 (es) | 2008-03-10 |
EA019693B1 (ru) | 2014-05-30 |
AU2007240453B2 (en) | 2012-04-12 |
TWI378100B (en) | 2012-12-01 |
KR20090008246A (ko) | 2009-01-21 |
ES2399379T3 (es) | 2013-04-01 |
US20070249610A1 (en) | 2007-10-25 |
EP2010538A1 (en) | 2009-01-07 |
IL194715A (en) | 2013-10-31 |
CL2010000554A1 (es) | 2010-10-15 |
AR060622A1 (es) | 2008-07-02 |
TW200808799A (en) | 2008-02-16 |
US7671199B2 (en) | 2010-03-02 |
KR101423789B1 (ko) | 2014-07-30 |
MX2008013232A (es) | 2008-10-21 |
SI2010538T1 (sl) | 2013-06-28 |
CN101472927A (zh) | 2009-07-01 |
DK2010538T3 (da) | 2013-03-18 |
BRPI0710691A2 (pt) | 2011-08-23 |
CN101472927B (zh) | 2012-07-04 |
CA2650059A1 (en) | 2007-11-01 |
PL2010538T3 (pl) | 2013-04-30 |
PT2010538E (pt) | 2013-02-22 |
NO20084326L (no) | 2008-11-18 |
WO2007124332A1 (en) | 2007-11-01 |
JP5203353B2 (ja) | 2013-06-05 |
HRP20130099T1 (hr) | 2013-03-31 |
EP2010538B1 (en) | 2012-12-05 |
CL2007001141A1 (es) | 2008-01-18 |
JP2009534413A (ja) | 2009-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200702614A1 (ru) | Способы получения 4-(бифенилил)азетидин-2-оналкилфосфиновых кислот | |
TW200736221A (en) | Novel pharmaceutical salts and polymorphs of a Factor Xa inhibitor | |
NZ592497A (en) | Derivatives of 1-amino-2-cyclobutylethylboronic acid | |
RS52823B (en) | NEW UNITS USEFUL FOR TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES | |
EA201200741A1 (ru) | Способ получения этексилата дабигатрана | |
EA200971104A1 (ru) | Производные бензимидазола | |
ATE542813T1 (de) | 6-substituierte 2- heterocyclylaminopyrazinverbindungen als chk-1- inhibitoren | |
EA200800047A1 (ru) | Производные пиримидина | |
WO2007085895A3 (en) | Fap inhibitors | |
UA107175C2 (uk) | Спосіб і сполука, призначені для одержання інгібіторів контранспортера натрій-глюкози 2 типу, варіанти | |
EA201390579A1 (ru) | Производные хиназолин-4(3h)-она, используемые как ингибиторы pi3-киназы | |
EA201200669A1 (ru) | ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα | |
UA107652C2 (en) | Carbazole compounds and therapeutic uses of the compounds | |
EA200801608A1 (ru) | Производные бензимидазолонкарбоновой кислоты | |
NZ625593A (en) | Purine derivatives useful as hsp90 inhibitors | |
EA200900090A1 (ru) | Бензиламины, способ их получения и их применение в качестве противовоспалительных средств | |
EA200801893A1 (ru) | Производные тетрагидронафталина, способ их получения и их применение в качестве ингибиторов воспаления | |
UA107562C2 (uk) | Спосіб лікування псоріазу | |
AU2010356056A8 (en) | Phosphoric acid ester compound of hydroxy acid substituted phenyl ester, synthesis method and medical use thereof | |
EA201070670A1 (ru) | Являющиеся антагонистами рнк соединения для модуляции экспрессии pik3ca | |
MA32290B1 (fr) | Nouvelle classe de spiro pipéridines pour le traitement de maladies neurodégénératives | |
EA200601678A1 (ru) | Новые имидазолы | |
EA200700550A1 (ru) | Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств | |
EA200802171A1 (ru) | СПОСОБ ПОЛУЧЕНИЯ 2-[4-(4-ФТОР-2-МЕТИЛ-1H-ИНДОЛ-5-ИЛОКСИ)-5-МЕТИЛПИРРОЛО[2,1-f][1,2,4]ТРИАЗИН-6-ИЛОКСИ]-1-МЕТИЛЭТИЛОВОГО ЭФИРА [(1R),2S]-2-АМИНОПРОПИОНОВОЙ КИСЛОТЫ | |
EA201270237A1 (ru) | Способ получения 1-бензил-3-гидроксиметил-1н-индазола и его производных и необходимые промежуточные соединения, содержащие магний |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): RU |